Search Results for "By Carrier Screening And Prenatal Diagnosis"
Original Source: Experience with Carrier Screening and Prenatal Diagnosis for Sixteen Ashkenazi Jewish Genetic Diseases.
The success of prenatal carrier screening as a disease prevention strategy in the Ashkenazi Jewish (AJ) population has driven the expansion of screening panels as disease-causing founder mutations have been identified. However, the carrier frequencies of many of these mutations have not been reported in large AJ cohorts. We determined the carrier frequencies of over 100 mutations for 16 recessive disorders in the New York metropolitan area AJ population. Among the 100% AJ-descended individuals, screening fo...
Matching Channels
Matching News
Important New Policy Statement On 'Noninvasive Prenatal Screening For Fetal Aneuploidy'
The American College of Medical Genetics and Genomics (ACMG) has just released an important new Policy Statement on "Noninvasive Prenatal Screening for Fetal Aneuploidy." The Statement can be found in...
Featured in the May edition of the Journal of Obstetrics and Gynaecology Canada is a new guide to help doctors, nurses and midwives counsel their patients about prenatal genetic screening. One of the...
Prenatal Testing with Cell-Free DNA Demonstrated Clinical Benefit
Noninvasive prenatal testing has clinical benefit over conventional prenatal screening tests, and at a price point of USD 795,...
ACMG supports use of non-invasive prenatal screening in women with singleton pregnancies
The American College of Medical Genetics issued a position statement to support the use of non-invasive prenatal screening in women with singleton pregnancies.
New ACMG statement on Noninvasive Prenatal Screening for Fetal Aneuploidy
The American College of Medical Genetics and Genomics has just released an important new Policy Statement on "Noninvasive Prenatal Screening for Fetal Aneuploidy."
Microarray analysis ‘best test for prenatal diagnosis’
Chromosomal microarray analysis is able to identify significantly more clinically relevant information for prenatal diagnosis than is karyotyping, and is equally able to highlight aneuploidies and unb...
Echevarne to distribute Natera's non-invasive prenatal screening test in Spain
Natera, a leading innovator in prenatal genetic testing, and Echevarne, a leading clinical analysis laboratory in Spain, today announced the signing of a distribution agreement for Echevarne to offer...
Natera Grabs $55M For Push into Prenatal Genetic Screening
Two months after jumping into the market with a non-invasive prenatal screening test for Down syndrome and other genetic disorders, San Carlos, CA-based Natera is raising a lot of investment cash to s...
Matching PubMed Articles
The success of prenatal carrier screening as a disease prevention strategy in the Ashkenazi Jewish (AJ) population has driven the expansion of screening panels as disease-causing founder mutations hav...
Background: Preconception carrier screening for hemoglobinopathies (HbPs) is debated in the Netherlands. Objectives: Intentions to participate in preconception carrier screening for HbPs as well as in...
Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
Cystic fibrosis (CF) carrier testing can be used to inform reproductive decision making, allowing carriers to avoid having a child with CF. A government-funded, population-based CF carrier screening p...
Prenatal genetic screening and diagnosis for pediatricians.
PURPOSE OF REVIEW: Prenatal genetic screening and diagnostic testing can identify many disorders that will require specialized newborn care and follow-up. Pediatricians should be aware of recent advan...
Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009.
OBJECTIVE: To analyze trends in the number and type of invasive procedure, reasons for referral, maternal age and chromosomal abnormalities over a 10-year period and correlate the trends to changes in...
